Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability Read more April 25, 2024 Edwards Lifesciences Reports First Quarter Results Read more April 25, 2024 Edwards Life
公司还通过RESILIA技术在外科领域的应用及Cordella心力衰竭管理设备等创新扩展业务版图。 增长驱动因素与战略布局 TAVR市场渗透与技术迭代:SAPIEN 3 Ultra RESILIA系统的推广和EARLY TAVR临床试验的进展将进一步提升TAVR在早期疾病阶段的应用。 TMTT领域的突破:EVOQUE系统已在美国获批用于三尖...
Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, and Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve System Indications:The Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve system is indicated for relief of aortic stenosis in patients with symptomatic heart ...
在美国,爱德华生命科学对 SAPIEN 3 Ultra RESILIA 平台的持续扩展和采用仍然感到满意。该技术建立在爱德华生命科学在组织技术和耐用性方面的领先地位之上,将组织科学的进步与行业领先的 SAPIEN 3 Ultra 瓣膜相结合,为当今美国患者提供唯一的干式存储经导管心脏瓣膜。 爱德华生命科学仍然相信,TAVR 的未来仍然强劲,这得益于...
投资者大会讨论了SAPIEN平台在TAVR领域的领导地位,以及即将到来的里程碑事件,如SAPIEN 3 Ultra RESILIA系统的采用和EARLY TAVR关键试验。在TMTT领域,公司正在推进EVOQUE和PASCAL Precision系统的商业化,并预计SAPIEN M3系统将获得CE认证。 第三方广告。非Investing.com产品或者推荐。点击此处查看声明或者移除广告。 Edwards还...
In the first quarter of 2025, theTranscatheter Aortic Valve Replacement (TAVR)arm is likely to have delivered a strong performance in the United States, thanks to its market-leading SAPIEN 3 Ultra RESILIA platform. The ongoing launch of SAPIEN 3 Ultra RESILIA in Europe is expected to have supp...
Outside the United States, TAVR sales growth was supported by the continued launch of SAPIEN 3 Ultra RESILIA in Europe. Management anticipates TAVR growth momentum to continue as centers gradually adopt these new therapies and become part of extended processes. In Japan, EW continues to focus on...
▲Sapien 3 Ultra Resilia 该公司预计,其产品Sapien 3 Ultra Resilia将在2023年大量采用。公司还表示,其EARLY TAVR关键性试验已全部入组,并在后续进程中不断推进。公司还预计其下一代Sapien X4的PROGRESS试验和ALLIANCE试验将继续招募参与者。 ▲Pascal Precision平台 ...
(TAVR) therapy, the SAPIEN 3 platform, for severe aortic stenosis (AS) patients without symptoms, marking the first FDA approval for TAVR in asymptomatic patients. Approval of the SAPIEN 3 platform (SAPIEN 3, SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA) is based on groundbreaking data from ...
Sure. Our folks probably answer questions about that on a regular basis. What we know is, we’re just really pleased with the SAPIEN 3 and especially the SAPIEN 3 Ultra performance. We think people have relied on it, not just normally but even during this pandemic. I think the performance...